Prosecution Insights
Last updated: April 19, 2026

Edigene (Guangzhou) Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18028464 USE OF COMPOUND FOR IMPROVING TRANSPLANTATION EFFICIENCY OF HUMAN HEMATOPOIETIC STEM CELLS GU, QINHUA 1633 Non-Final OA Mar 24, 2023
17640759 METHOD FOR EVALUATING GENE EDITING THERAPY BASED ON OFF-TARGET ASSESSMENT ZAHORIK, AMANDA MARY 1636 Non-Final OA Mar 04, 2022

Managing Edigene (Guangzhou) Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month